Zimmer Biomet Holdings Inc
Research Zimmer Biomet Holdings Inc (ZBH) on Bullrun: valuation model: fairly valued, market cap USD 19.11B, P/E 24.4, dividend yield 1.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZBH
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryMedical Devices
- CurrencyUSD
- Valuation signalfairly valued
- Market capUSD 19.11B
- P/E24.4
- Dividend yield1.0%
- Financial periodQ2 2026
- RevenueUSD 2.18B
- Net incomeUSD 198.30M
- Free cash flowUSD 331.40M
- Gross margin70.8%
Valuation Snapshot
Bullrun's latest valuation model marks Zimmer Biomet Holdings Inc as fairly valued; latest market cap is USD 19.11B; P/E is 24.4; dividend yield is 1.0%.
Peer valuation comparison
Latest P/E is 24.39x versus a Healthcare sector median of 24.46x.
Latest dividend yield is 0.97% versus a Healthcare sector median of 2.11% (54.0% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 8.23B | USD 705.10M | USD 1.47B | 69.7% | 3.55 | USD 591.90M | USD 7.52B | USD 12.70B |
| FY2024 | USD 7.68B | USD 903.80M | USD 1.30B | 71.5% | 4.43 | USD 525.50M | USD 6.20B | USD 12.47B |
| FY2023 | USD 7.39B | USD 1.02B | USD 1.29B | 71.8% | 4.88 | USD 415.80M | USD 5.77B | USD 12.48B |
| FY2022 | USD 6.94B | USD 231.40M | USD 1.17B | 70.9% | 1.1 | USD 375.70M | USD 5.70B | USD 12.02B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 19.11B | 24.4 | 1.0% | 0.96 |
| 2025 | 2025-12-31 | USD 17.58B | 25.3 | 1.1% | 0.96 |
| 2024 | 2024-12-31 | USD 21.03B | 23.8 | 0.9% | 0.96 |
| 2023 | 2023-12-29 | USD 25.43B | 53.8 | 0.8% | 0.96 |
| 2022 | 2022-12-30 | USD 26.76B | 96.6 | 0.8% | 0.96 |
| 2021 | 2021-12-31 | USD 25.78B | 64.6 | 0.7% | 0.92 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.96 USD, yield 1.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 0.96 USD |
| FY2024 | 0.96 USD |
| FY2023 | 0.96 USD |
| FY2022 | 0.96 USD |
About Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, upper extremities, and trauma and CMFT products; sports medicine products for the repair of soft tissue injuries, used in the knee and shoulder;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is Zimmer Biomet Holdings Inc overvalued or undervalued?
Bullrun's valuation model currently marks Zimmer Biomet Holdings Inc as fairly valued.
What is Zimmer Biomet Holdings Inc's market cap?
Zimmer Biomet Holdings Inc's market capitalization is USD 19.11B.
What is Zimmer Biomet Holdings Inc's P/E ratio?
Zimmer Biomet Holdings Inc's price-to-earnings (P/E) ratio is 24.4.
Does Zimmer Biomet Holdings Inc pay a dividend?
Zimmer Biomet Holdings Inc has a dividend yield of 1.0%.
What does Zimmer Biomet Holdings Inc do?
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.